Clay Thorp
CIK 1592380 · last filed 2025-02-24
Clay Thorp is a corporate insider who has filed 49 SEC Form 4 insider transactions across 3 companies since 2016. The most recent filing shows the insider bought $13.8K of CLSD on Feb 24, 2025. Across all open-market trades the lifetime net is +$23.3M, making them a net buyer over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
49
$23.32M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Clearside Biomedical, Inc. (CLSD) Delisted | Director | 3,721,181 | $0.35 | $1.31M | $17.97M | 33 | 2025-02-24 |
| PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Director | 48,375 | $0.07 | $3.4K | $1.51M | 12 | 2022-05-20 |
| Vigil Neuroscience, Inc. (VIGL) Delisted | Director | 1,544,137 | $8.05 | $12.43M | $3.84M | 3 | 2022-05-17 |
Recent Filings
49 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-02-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +15,000 | $13.8K | EDGAR |
| 2024-06-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-09-25 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +10,000 | $8.6K | EDGAR |
| 2023-06-23 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-19 | — | Exer (M) | +3,750 | $0 | |
| 2022-12-21 | Clearside Biomedical, Inc. (CLSD) Delisted | Buy (P) | +14,000 | $14.3K | EDGAR |
| 2022-12-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Other (J) | −1,397,985 | $0 | EDGAR |
| 2022-12-19 | Clearside Biomedical, Inc. (CLSD) Delisted | Sell (S) | −32,873 | -$145.6K | EDGAR |
| 2022-06-24 | Clearside Biomedical, Inc. (CLSD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-05-20 | PhaseBio Pharmaceuticals Inc (PHAS) Delisted | Grant (A) | — | $0 | EDGAR |